Lexicon Pharmaceuticals (LXRX) Reports In-Line Q4 EPS

February 21, 2013 6:29 AM EST Send to a Friend
Get Alerts LXRX Hot Sheet
Price: $1.02 +2.00%

Financial Fact:
Total revenues: 419K

Today's EPS Names:
RADA, NTZ, More
Trade LXRX Now!
Join SI Premium – FREE
Lexicon Pharmaceuticals (NASDAQ: LXRX) reported Q4 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $218 thousand versus the consensus estimate of $370 thousand.

For earnings history and earnings-related data on Lexicon Pharmaceuticals (LXRX) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings

Add Your Comment